Repaglinide Teva
repaglinide
Keep this leaflet. You may need to read it again.
If you have any further questions, ask your doctor or pharmacist.
This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.
What Repaglinide Teva is and what it is used for
What you need to know before you take Repaglinide Teva
How to take Repaglinide Teva
5. Possible side effects
How to store Repaglinide Teva
Contents of the pack and other information
Repaglinide Teva is an oral antidiabetic medicine containing repaglinide which helps your pancreas produce more insulin and thereby lower your blood sugar (glucose).
Repaglinide Teva is used to control type 2 diabetes in adults as an add-on to diet and exercise: treatment is usually started if diet, exercise and weight reduction alone have not been able to control (or lower) your blood sugar. Repaglinide Teva can also be given with metformin, another medicine for diabetes.
Repaglinide has been shown to lower the blood sugar, which helps to prevent complications from your diabetes.
If you are allergic to repaglinide or any of the other ingredients in this medicine (listed in section 6).
If you have type 1 diabetes.
If the acid level in your blood is raised (diabetic ketoacidosis).
If you have a severe liver disease.
If you take gemfibrozil (a medicine used to lower increased fat levels in the blood).
Talk to your doctor before taking Repaglinide Teva:
If you have liver problems. Repaglinide Teva is not recommended in patients with moderate liver disease. Repaglinide Teva should not be taken if you have a severe liver disease (see Do not take Repaglinide Teva).
If you have kidney problems. Repaglinide Teva should be taken with caution.
If you are about to have major surgery or you have recently suffered a severe illness or
If you are under 18 or over 75 years of age. Repaglinide Teva is not recommended. It has not been studied in these age groups.
Do not take this medicine if you are under 18 years of age.
You may get a hypo (short for hypoglycaemia) if your blood sugar gets too low. This may happen:
If you take too much Repaglinide Teva.
If you exercise more than usual.
If you take other medicines or suffer from liver or kidney problems (see other sections of
2. What you need to know before you take Repaglinide Teva).
continue Repaglinide Teva treatment.
Your blood sugar may get too high (hyperglycaemia). This may happen:
If you take too little Repaglinide Teva.
If you have an infection or a fever.
If you eat more than usual.
If you exercise less than usual.
You can take Repaglinide Teva with metformin, another medicine for diabetes, if your doctor prescribes it. If you take gemfibrozil (used to lower increased fat levels in the blood) you should not take Repaglinide Teva.
Your body’s response to Repaglinide Teva may change if you take other medicines, especially these:
Monoamine oxidase inhibitors (MAOI) (used to treat depression).
Beta blockers (used to treat high blood pressure or heart conditions).
ACE-inhibitors (used to treat heart conditions).
Salicylates (e.g. aspirin).
Octreotide (used to treat cancer).
Nonsteroidal anti-inflammatory drugs (NSAID) (a type of painkillers).
Steroids (anabolic steroids and corticosteroids – used for anemia or to treat inflammation).
Oral contraceptives (birth control pills).
Thiazides (diuretics or ‘water pills’).
Danazol (used to treat breast cysts and endometriosis).
Thyroid products (used to treat low levels of thyroid hormones).
Sympathomimetics (used to treat asthma).
Clarithromycin, trimethoprim, rifampicin (antibiotic medicines).
Itraconazole, ketokonazole (antifungal medicines).
Gemfibrozil (used to treat high blood fats).
Ciclosporin (used to suppress the immune system).
Deferasirox (used to reduce chronic iron overload).
Clopidogrel (prevents blood clots).
Phenytoin, carbamazepine, phenobarbital (used to treat epilepsy).
St. John’s wort (herbal medicine).
Alcohol can change the ability of Repaglinide Teva to reduce the blood sugar. Watch for signs of a hypo.
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before taking this medicine.
You should not take Repaglinide Teva if you are pregnant or you are planning to become pregnant. You should not take Repaglinide Teva if you are breast-feeding.
Your ability to drive or use a machine may be affected if your blood sugar is low or high. Bear in mind that you could endanger yourself or others. Please ask your doctor whether you can drive a car if you:
have frequent hypos,
have few or no warning signs of hypos.
Always take this medicine exactly as your doctor has told you. Check with your doctor if you are not sure.
Your doctor will work out your dose.
The dose may be adjusted by your doctor by up to 4 mg to be taken immediately before or up to 30 minutes before each main meal. The maximum recommended daily dose is 16 mg.
Do not take more Repaglinide Teva than your doctor has recommended.
If you take too many tablets, your blood sugar may become too low, leading to a hypo. Please see If you get a hypo on what a hypo is and how to treat it.
If you miss a dose, take the next dose as usual - do not take a double dose to make up for a forgotten dose.
Be aware that the desired effect is not achieved if you stop taking Repaglinide Teva. Your diabetes may get worse. If any change of your treatment is necessary contact your doctor first.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them. Hypoglycaemia
The most frequent side effect is hypoglycaemia which may affect up to 1 in 10 patients (see If you get
a hypo in section 2). Hypoglycaemic reactions are generally mild/moderate but may occasionally develop into hypoglycaemic unconsciousness or coma. If this happens, medical assistance is needed immediately.
Allergy
Allergy is very rare (may affect up to 1 in 10,000 patients). Symptoms such as swelling, difficulty in breathing, rapid heartbeat, feeling dizzy and sweating could be signs of anaphylactic reaction. Contact a doctor immediately.
Other side effects
Stomach pain
Diarrhoea.
Acute coronary syndrome (but it may not be due to the medicine).
Vomiting
Constipation
Visual disturbances
Severe liver problems, abnormal liver function such as increased liver enzymes in your blood.
Hypersensitivity (such as rash, itchy skin, reddening of the skin, swelling of the skin)
Feeling sick (nausea).
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed in Appendix V. By reporting side effects you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton and blister foil after EXP. The expiry date refers to the last day of that month.
Store in the original package in order to protect from light.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
The active substance is repaglinide.
Each Repaglinide Teva 0.5 mg tablet contains 0.5 mg of repaglinide. Each Repaglinide Teva 1 mg tablet contains 1 mg of repaglinide. Each Repaglinide Teva 2 mg tablet contains 2 mg of repaglinide.
The other ingredients are: microcrystalline cellulose (E460), meglumine, poloxamer 188, povidone K-30, calcium hydrogen phosphate, colloidal silicon dioxide anhydrous, polacrilin potassium, maize starch, magnesium stearate,
indigo carmine aluminium (E132) (0.5 mg tablet only), iron oxide yellow (E172) (1 mg tablet only), iron oxide red (E172) (2 mg tablet only).
Repaglinide Teva 0.5 mg tablet is a light blue to blue, capsule shaped tablet, debossed with "93" on one side and “210” on the other side of the tablet.
Repaglinide Teva 1 mg tablet is a yellow to light yellow, capsule shaped tablet, debossed with "93" on one side and “211” on the other side of the tablet.
Repaglinide Teva 2 mg tablet is a mottled peach, capsule shaped tablet, debossed with "93" on one side and “212” on the other side of the tablet.
Repaglinide Teva is available in pack sizes of 30, 90, 120, 270 and 360 tablets. Not all pack sizes may be marketed.
Teva B.V. Swensweg 5
2031 GA Haarlem The Netherlands
Teva Pharmaceutical Works Private Limited Company
Pallagi út 13. Debrecen H-4042 Hungary
Pharmachemie B.V. Swensweg 5
2031 GA Haarlem The Netherlands
GALIEN LPS
98 rue Bellocier
89100 Sens France
Merckle GmbH
Ludwig-Merckle-Straße 3,
89143 Blaubeuren-Weiler Germany
TEVA PHARMA S.L.U
C/ C, n° 4, Polígono Industrial Malpica, 50016 Zaragoza
Spain
For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder:
Teva Pharma Belgium N.V./S.A./AG Tél/Tel: +32 38207373
UAB Teva Baltics Tel: +370 52660203
Тева Фарма ЕАД Teл: +359 24899585
Teva Pharma Belgium N.V./S.A./AG Belgique/Belgien
Tél/Tel: +32 38207373
Teva Pharmaceuticals CR, s.r.o. Tel: +420 251007111
Teva Gyógyszergyár Zrt. Tel: +36 12886400
Teva Denmark A/S Tlf: +45 44985511
Teva Pharmaceuticals Ireland L-Irlanda
Tel: +44 2075407117
TEVA GmbH
Tel: +49 73140208
Teva Nederland B.V. Tel: +31 8000228400
UAB Teva Baltics Eesti filiaal Tel: +372 6610801
Teva Norway AS Tlf: +47 66775590
Specifar A.B.E.E.
Τηλ: +30 2118805000
ratiopharm Arzneimittel Vertriebs-GmbH Tel: +43 1970070
Teva Pharma, S.L.U. Tel: +34 913873280
Teva Pharmaceuticals Polska Sp. z o.o. Tel: +48 223459300
Teva Santé
Tél: +33 155917800
Teva Pharma - Produtos Farmacêuticos, Lda. Tel: +351 214767550
Pliva Hrvatska d.o.o. Tel: +385 13720000
Teva Pharmaceuticals S.R.L. Tel: +40 212306524
Teva Pharmaceuticals Ireland Tel: +44 2075407117
Pliva Ljubljana d.o.o. Tel: +386 15890390
Teva Pharma Iceland ehf. Sími: +354 5503300
TEVA Pharmaceuticals Slovakia s.r.o. Tel: +421 257267911
Teva Italia S.r.l. Tel: +39 028917981
Teva Finland Oy
Puh/Tel: +358 201805900
Specifar A.B.E.E.
Ελλάδα
Τηλ: +30 2118805000
Teva Sweden AB Tel: +46 42121100
UAB Teva Baltics filiāle Latvijā Tel: +371 67323666
Teva Pharmaceuticals Ireland Ireland
Tel: +44 2075407117